Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 7745 - 7752 of 12107 results

Full Seventh Circuit Bench to Decide Whether Title VII Prohibits Sexual Orientation Discrimination

October 24, 2016| Blog| Viewpoint

Reminder: Pharmaceutical Industry Enforcement Webinar - Wednesday, October 26

October 24, 2016| Blog| Viewpoint

3 Guidelines to Maximize Value of Data

October 24, 2016| Blog| Viewpoint

Providers, Pharmacists Call for Earlier FDA Guidance on Biosimilars

October 24, 2016| News

DHS to Increase Filing Fees Effective 12/23/2016

October 24, 2016| Alert| Viewpoint

Analyzing Patent Claims Having Conditional Language – the PTAB Provides Clarity

October 21, 2016| Blog| Viewpoint

Coming Soon to a Lawbook Near You - New Cosmetic Requirements

October 21, 2016| Blog| Viewpoint

Updates on Privacy and Security in the EU

October 20, 2016| Blog| Viewpoint

News & Press Releases

Mintz Honored with NLADA Beacon of Justice Award

August 21, 2025

Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.

SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals

August 19, 2025

Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.

Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree

August 19, 2025

Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.

View all News and Press Releases